Home › Funds › Steadfast Capital Management › ABT
Steadfast Capital Management position in ABT
ABBOTT LABORATORIES · Health Care
Latest position (Q4 2021)21.92K sh
Reported value held$3.09M
Portfolio Weight3.68%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.94M | $228.70M | New |
| Q4 2021 | 21.92K | $3.09M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- BlackRock Inc 152.56M sh · $13.84B · Q2 2026
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- Geode Capital Management 39.22M sh · $3.54B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Morgan Stanley 26.61M sh · $2.41B · Q2 2026
- Norges Bank Investment Management 23.35M sh · $2.12B · Q2 2026
- Franklin Resources 18.81M sh · $1.71B · Q2 2026
- Goldman Sachs Group 18.60M sh · $1.69B · Q2 2026
- Northern Trust Corp 18.27M sh · $1.66B · Q2 2026
- Bank of America Corp 17.67M sh · $1.60B · Q2 2026
- Deutsche Bank AG 16.71M sh · $1.52B · Q2 2026